You're viewing 1 of thousands of executive moves tracked weekly
Members get notified within hours of C-level changes at target companies. Filter by title, industry, and company size to find your next opportunity.
Seres Therapeutics Announces the Appointment of Marella Thorell As Chief Financial Officer and the Retirement of David Arkowitz
Seres Therapeutics Announces the Appointment of Marella Thorell As Chief Financial Officer and the Retirement of David Arkowitz
02/26/24, 12:02 PM
Location
cambridgeIndustry
therapeutics
biotechnology
health care
Position
executive vice president
chief financial officer
Seres Therapeutics, Inc. announces the appointment of Marella Thorell as Executive Vice President and Chief Financial Officer (CFO), effective March 25th.
Company Info
Location
cambridge, massachusetts, united states
Additional Info
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Seres’ lead program, VOWST™, obtained U.S. FDA approval in April 2023 as the first orally administered microbiome therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science.
Live intelligence
Get deeper insights on Seres Therapeutics's new executives
✓
Direct contact info for 1 executives
✓
AI alerts when similar companies hire C-level talent
✓
Track strategic changes from new leadership
Used by teams at Oracle, Google, LinkedIn
Related people
MH